118 related articles for article (PubMed ID: 26230877)
1. Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonists.
Azuaje J; Carbajales C; González-Gómez M; Coelho A; Caamaño O; Gutiérrez-de-Terán H; Sotelo E
Future Med Chem; 2015; 7(11):1373-80. PubMed ID: 26230877
[TBL] [Abstract][Full Text] [Related]
2. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A
Poli D; Falsini M; Varano F; Betti M; Varani K; Vincenzi F; Pugliese AM; Pedata F; Dal Ben D; Thomas A; Palchetti I; Bettazzi F; Catarzi D; Colotta V
Eur J Med Chem; 2017 Jan; 125():611-628. PubMed ID: 27721147
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel A3 adenosine receptor ligands based on chromone scaffold.
Gaspar A; Reis J; Kachler S; Paoletta S; Uriarte E; Klotz KN; Moro S; Borges F
Biochem Pharmacol; 2012 Jul; 84(1):21-9. PubMed ID: 22433284
[TBL] [Abstract][Full Text] [Related]
4. Correlation study between A
Yu J; Kim G; Jarhad DB; Lee HW; Lee J; Park CW; Ha H; Jeong LS
Arch Pharm Res; 2019 Sep; 42(9):773-779. PubMed ID: 30264323
[TBL] [Abstract][Full Text] [Related]
5. Effect of Nitrogen Atom Substitution in A
Azuaje J; Jespers W; Yaziji V; Mallo A; Majellaro M; Caamaño O; Loza MI; Cadavid MI; Brea J; Åqvist J; Sotelo E; Gutiérrez-de-Terán H
J Med Chem; 2017 Sep; 60(17):7502-7511. PubMed ID: 28792759
[TBL] [Abstract][Full Text] [Related]
6. Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.
Ranganathan A; Stoddart LA; Hill SJ; Carlsson J
J Med Chem; 2015 Dec; 58(24):9578-90. PubMed ID: 26592528
[TBL] [Abstract][Full Text] [Related]
7. A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists.
Venkatesan G; Paira P; Cheong SL; Federico S; Klotz KN; Spalluto G; Pastorin G
Eur J Med Chem; 2015 Mar; 92():784-98. PubMed ID: 25633494
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Optimization of Coumarin hA
Matos MJ; Vilar S; Vazquez-Rodriguez S; Kachler S; Klotz KN; Buccioni M; Delogu G; Santana L; Uriarte E; Borges F
J Med Chem; 2020 Mar; 63(5):2577-2587. PubMed ID: 31738058
[TBL] [Abstract][Full Text] [Related]
9. Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agents.
Paoletta S; Federico S; Spalluto G; Moro S
Methods Enzymol; 2010; 485():225-44. PubMed ID: 21050920
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of DPTN and other selective A
Gao ZG; Suresh RR; Jacobson KA
Purinergic Signal; 2021 Dec; 17(4):737-746. PubMed ID: 34713378
[TBL] [Abstract][Full Text] [Related]
11. Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A
Xia L; Burger WAC; van Veldhoven JPD; Kuiper BJ; van Duijl TT; Lenselink EB; Paasman E; Heitman LH; IJzerman AP
J Med Chem; 2017 Sep; 60(17):7555-7568. PubMed ID: 28806076
[TBL] [Abstract][Full Text] [Related]
12. Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation.
Varano F; Catarzi D; Squarcialupi L; Betti M; Vincenzi F; Ravani A; Varani K; Dal Ben D; Thomas A; Volpini R; Colotta V
Eur J Med Chem; 2015; 96():105-21. PubMed ID: 25874336
[TBL] [Abstract][Full Text] [Related]
13. Current Status in the Design and Development of Agonists and Antagonists of Adenosine A3 Receptor as Potential Therapeutic Agents.
Mailavaram RP; Al-Attraqchi OHA; Kar S; Ghosh S
Curr Pharm Des; 2019; 25(25):2772-2787. PubMed ID: 31333098
[TBL] [Abstract][Full Text] [Related]
14. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Filacchioni G; Varani K; Corciulo C; Vincenzi F; Borea PA; Ghelardini C; Di Cesare Mannelli L; Ciancetta A; Moro S
J Med Chem; 2013 Mar; 56(6):2256-69. PubMed ID: 23427825
[TBL] [Abstract][Full Text] [Related]
15. Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.
Saíz-Urra L; Teijeira M; Rivero-Buceta V; Helguera AM; Celeiro M; Terán MC; Besada P; Borges F
Mol Divers; 2016 Feb; 20(1):55-76. PubMed ID: 26205409
[TBL] [Abstract][Full Text] [Related]
16. Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor.
Squarcialupi L; Catarzi D; Varano F; Betti M; Falsini M; Vincenzi F; Ravani A; Ciancetta A; Varani K; Moro S; Colotta V
Eur J Med Chem; 2016 Jan; 108():117-133. PubMed ID: 26638043
[TBL] [Abstract][Full Text] [Related]
17. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
[TBL] [Abstract][Full Text] [Related]
18. The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.
Poli D; Catarzi D; Colotta V; Varano F; Filacchioni G; Daniele S; Trincavelli L; Martini C; Paoletta S; Moro S
J Med Chem; 2011 Apr; 54(7):2102-13. PubMed ID: 21401121
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterisation of novel adenosine A
Barkan K; Lagarias P; Stampelou M; Stamatis D; Hoare S; Safitri D; Klotz KN; Vrontaki E; Kolocouris A; Ladds G
Sci Rep; 2020 Nov; 10(1):20781. PubMed ID: 33247159
[TBL] [Abstract][Full Text] [Related]
20. Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor.
Tosh DK; Paoletta S; Chen Z; Moss SM; Gao ZG; Salvemini D; Jacobson KA
Bioorg Med Chem Lett; 2014 Aug; 24(15):3302-6. PubMed ID: 24969016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
